Metabolic memory phenomenon in diabetes mellitus: Achieving and perspectives

被引:94
作者
Berezin, Alexander [1 ]
机构
[1] State Med Univ Zaporozhye, Dept Internal Med, 26 Mayakovsky Ave, UA-69035 Zaporozhe, Ukraine
关键词
Diabetes mellitus; Metabolic memory phenomenon; Oxidative stress; Inflammation; Epigenetic modulation;
D O I
10.1016/j.dsx.2016.03.016
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Diabetes mellitus (DM) exhibits raised prevalence worldwide. There is a large body of evidence regarding the incidence of DM closely associates with cardiovascular (CV) complications. In this context, hyperglycaemia, oxidant stress, and inflammation are key factors that contribute in CV events and disease in type1 and type 2 DM, even when metabolic control was optimal and/or intensive glycemic control was implemented. It has been suggested that the effect of poor metabolic control or even transient episodes of hyperglycemia in DM associates in particularly with worsening ability of endogenous vasoreparative systems that are mediated epigenetic changes in several cells (progenitor cells, stem cells, mononuclears, immune cells), and thereby lead to so called "vascular glycemic memory" or "metabolic memory". Both terms are emphasized the fact that prior glucose control has sustained effects that persist even after return to more usual glycemic control. The mechanisms underlying the cellular "metabolic memory" induced by high glucose remain unclear. The review is discussed pathophysiology and clinical relevance of "metabolic" memory phenomenon in DM. The role of oxidative stress, inflammation, and epigenetics in DM and its vascular complications are highlighted. The effects of several therapeutic approaches are discussed. (C) 2016 Diabetes India. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:S176 / S183
页数:8
相关论文
共 101 条
[1]   Perspectives on diabetic retinopathy [J].
Aiello, LM .
AMERICAN JOURNAL OF OPHTHALMOLOGY, 2003, 136 (01) :122-135
[2]   Detection of β cell death in diabetes using differentially methylated circulating DNA [J].
Akirav, Eitan M. ;
Lebastchi, Jasmin ;
Galvan, Eva M. ;
Henegariu, Octavian ;
Akirav, Michael ;
Ablamunits, Vitaly ;
Lizardi, Paul M. ;
Herold, Kevan C. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (47) :19018-19023
[3]   Prolonged metformin treatment leads to reduced transcription of Nrf2 and neurotrophic factors without cognitive impairment in older C57BL/6J mice [J].
Allard, Joanne S. ;
Perez, Evelyn J. ;
Fukui, Koji ;
Carpenter, Priscilla ;
Ingram, Donald K. ;
de Cabo, Rafael .
BEHAVIOURAL BRAIN RESEARCH, 2016, 301 :1-9
[4]   Comparison of Treatment of Severe High-Density Lipoprotein Cholesterol Deficiency in Men With Daily Atorvastatin (20 mg) Versus Fenofibrate (200 mg) Versus Extended-Release Niacin (2 g) [J].
Alrasadi, Khalid ;
Awan, Zuhier ;
Alwaili, Khalid ;
Rue, Isabelle ;
Hafiane, Anouar ;
Krimbou, Larbi ;
Genest, Jacques .
AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (10) :1341-1347
[5]   Sitagliptin, a dipeptidyl peptidase-4 inhibitor, increases the number of circulating CD34+CXCR4+ cells in patients with type 2 diabetes [J].
Aso, Yoshimasa ;
Jojima, T. ;
Iijima, T. ;
Suzuki, K. ;
Terasawa, T. ;
Fukushima, M. ;
Momobayashi, A. ;
Hara, K. ;
Takebayashi, K. ;
Kasai, K. ;
Inukai, T. .
ENDOCRINE, 2015, 50 (03) :659-664
[6]   Treating diabetes today with gliclazide MR: a matter of numbers [J].
Avogaro, A. .
DIABETES OBESITY & METABOLISM, 2012, 14 :14-19
[7]   Hyperglycemia and Vascular Metabolic Memory: Truth or Fiction? [J].
Bianchi, Cristina ;
Miccoli, Roberto ;
Del Prato, Stefano .
CURRENT DIABETES REPORTS, 2013, 13 (03) :403-410
[8]   Achieving International Society for Pediatric and Adolescent Diabetes and American Diabetes Association clinical guidelines offers cardiorenal protection for youth with type 1 diabetes [J].
Bjornstad, Petter ;
Pyle, Laura ;
Nhung Nguyen ;
Snell-Bergeon, Janet K. ;
Bishop, Franziska K. ;
Wadwa, R. Paul ;
Maahs, David M. .
PEDIATRIC DIABETES, 2015, 16 (01) :22-30
[9]   THE EMERGING ROLE OF ADJUNCTIVE NONINSULIN ANTIHYPERGLYCEMIC THERAPY IN THE MANAGEMENT OF TYPE 1 DIABETES [J].
Bode, Bruce W. ;
Garg, Satish K. .
ENDOCRINE PRACTICE, 2016, 22 (02) :220-230
[10]   Intensive glycemic control and cardiovascular disease: an update [J].
Brown, Aparna ;
Reynolds, L. Raymond ;
Bruemmer, Dennis .
NATURE REVIEWS CARDIOLOGY, 2010, 7 (07) :369-375